Return to search

HealthCor Catalio SPAC goes public

HealthCor Catalio Acquisition Corp, a blank check company backed by HealthCor Management LP and Catalio Capital Management LP, has raised $180 million for its IPO after pricing its 18 million shares at $10 per share.

HealthCor Catalio Acquisition Corp, a blank check company backed by HealthCor Management LP and Catalio Capital Management LP, has raised $180 million for its IPO after pricing its 18 million shares at $10 per share. The stock began trading January 27, 2021 on the NASDAQ under the ticker symbol “HCAQ.” Jefferies LLC was the sole underwriter.

PRESS RELEASE

NEW YORK, Jan. 26, 2021 /PRNewswire/ — HealthCor Catalio Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the pricing of its upsized initial public offering of 18,000,000 Class A ordinary shares at a price of $10.00 per share. The Company’s sponsor is owned by affiliates of HealthCor Management, L.P., which manages approximately $2.7 billion in assets across long/short and long only healthcare funds, and Catalio Capital Management, LP, a private equity firm that invests in breakthrough biomedical technology companies. The Company will be led by Christopher Gaulin, as Chief Executive Officer, Joe Healey, as Chairman of the Board of Directors, and George Petrocheilos, as President. The Company will be listed on the Nasdaq Capital Market and trade under the ticker symbol “HCAQ” beginning on January 27, 2021.

Jefferies LLC is serving as sole book-running manager for this offering. The Company has granted the underwriter a 45-day option to purchase up to an additional 2,700,000 shares at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, telephone: 877-821-7388 or email: Prospectus_Department@Jefferies.com.

A registration statement relating to the securities became effective on January 26, 2021 in accordance with Section 8(a) of the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering is expected to close on January 29, 2021, subject to customary closing conditions.